株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の幹細胞市場

The Global Market for Stem Cells

発行 BCC Research 商品コード 63236
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: BCC Research社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
世界の幹細胞市場 The Global Market for Stem Cells
出版日: 2016年05月24日 ページ情報: 英文 179 Pages
担当者のコメント
治療法概要から特許、市場状況、参入企業等を包括的に纏めています。
概要

世界の幹細胞製品市場は、2015年に約59億米ドルとなりました。同市場は2016年から2021年の期間中、CAGR13.1%で拡大し、2021年に123億米ドルへ達すると予測されています。

当レポートでは、世界の幹細胞市場について調査し、幹細胞研究の見通し、主要国・地域における現在の市場規模と成長率、幹細胞を支える重要な技術のレビュー、幹細胞産業の性質と構造の分析、近年のM&A活動を含む主要企業のプロファイル、および国・主要治療分野別による今後5ヵ年の市場予測などを提供しています。

第1章 イントロダクション

第2章 サマリー

  • 定義
  • アプリケーション
  • 研究・商業化
  • 資金
  • 市場

第3章 概要

  • 細胞
  • 幹細胞

第4章 幹細胞研究

  • 歴史
  • 細胞ベースの治療
  • 幹細胞研究の規制
  • 幹細胞研究・製造の実用性
    • 幹細胞製造
    • 幹細胞獲得
    • 幹細胞製造のエコノミクス
    • 新しい幹細胞製造の発展
    • 分離・エンジニアリング
    • 幹細胞バンク
    • ISCBIプロジェクト
    • 将来展望:オルガノイドの台頭

第5章 幹細胞のアプリケーション

  • 再生医療
  • 現在の幹細胞治療アプリケーション
    • 筋萎縮性側索硬化症(ALS)
    • パーキンソン病
    • 脊髄損傷
    • アルツハイマー病
    • 脳卒中
    • 心臓病
    • 末梢動脈疾患
    • 1型糖尿病
    • 整形外科修復
    • 肝不全
    • 移植片対宿主病(GVHD)
    • 肺疾患
    • 幹細胞治験の状況

第6章 幹細胞の特許

  • 特許の一般的背景
  • 幹細胞の特許
  • 各国の政策
    • 米国
    • カナダ
    • 英国
    • ドイツ
    • 日本
    • 中国
    • iPS細胞

第7章 幹細胞市場

  • 幹細胞市場
    • 市場成長促進因子
    • 心疾患
    • 中枢神経系疾患
    • 糖尿病
    • 骨格系
  • 世界市場の推計・予測
  • 地域・国別の市場分析

第8章 企業プロファイル

第9章 用語

第10章 注目の幹細胞研究特許

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BIO035F

The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1% from 2016 through 2021.

This report provides:

  • An overview of the global market for stem cells and related technologies
  • Analyses of global market trends, with data from 2014, 2015, estimates for 2016 and projections of compound annual growth rates (CAGRs) through 2021
  • Information on the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market
  • A look at the regulatory environment, healthcare policies, demographics, and other factors directly affecting stem cell-related markets
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Examination of strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market
  • Profiles of major players in the industry

REPORT SCOPE

SCOPE OF REPORT

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST'S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the stem cell marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • MARKET ANALYSES AND FORECASTS
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • DEFINITIONS
  • APPLICATIONS
  • RESEARCH AND COMMERCIALIZATION
  • FUNDING
  • MARKET
  • SUMMARY TABLE GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL STEM CELL MARKET BY REGION, 2014-2021 ($ MILLIONS)

CHAPTER 3 OVERVIEW

  • CELLS
  • STEM CELLS
  • FIGURE 1 EARLY DEVELOPMENT OF EMBRYO
    • INDUCED PLURIPOTENT STEM CELLS
      • Mesenchymal Stem Cells
        • hpSCS
    • THE CANCER PROBLEM
    • CANCER STEM CELLS-A WIDER TOPIC

CHAPTER 4 STEM CELL RESEARCH

  • HISTORY
    • EMBRYONIC STEM CELLS
      • Growth and Identification of ESCs
      • Stimulating ESCs to Differentiate
    • NEW CELL LINE
    • ADULT STEM CELLS
      • Mesenchymal Stem Cells (MSCs)
      • Hematopoietic Stem Cells (HSCs)
      • Neural Stem Cells (NSCs)
      • Endothelial Progenitor Cells (EPCs)
      • Epithelial Stem Cells (ESCs)
      • Very Small Embryonic-Like Cells (VSELs)
    • CORD BLOOD STEM CELLS
    • INDUCED PLURIPOTENT STEM CELLS (IPSCS)
      • Nuclear Reprogramming
  • CELL-BASED THERAPEUTICS
    • EMBRYONIC-DERIVED STEM CELLS
    • ADULT/PROGENITOR-DERIVED STEM CELLS
    • ENGINEERED SCS FOR TRANSPLANTATION
    • THERAPEUTIC STEM CELL BANKING
    • STEM CELL-BASED BIOMEDICAL RESEARCH
  • REGULATION OF STEM CELL RESEARCH
    • NATIONAL REGULATORY MEASURES
      • Australia
      • Brazil
      • Canada
      • China
      • France
      • Germany
      • India
      • Ireland
      • Israel
      • Italy
      • Japan
      • South Korea
      • Spain
      • Sweden
      • United Kingdom
      • United States
        • California
        • Massachusetts
        • Michigan
        • New Jersey
        • New York
      • FDA Approach
    • EUROPEAN UNION
  • PRACTICALITIES OF STEM CELL RESEARCH AND PRODUCTION
    • STEM CELL PRODUCTION
    • STEM CELL ACQUISITION
      • Characterization and Expansion
      • Maintenance and Storage
    • STEM CELL PRODUCTION ECONOMICS
      • Customized Therapy
      • Banks
    • NOVEL STEM CELL PRODUCTION DEVELOPMENTS
    • ISOLATION AND ENGINEERING
      • Adult Stem Cells
      • Embryonic Stem Cells
      • Induced Pluripotent Stem Cells
    • STEM CELL BANKING
    • ISCBI PROJECT
    • TABLE 1 COUNTRIES ENGAGED IN THE ISCBI PROGRAM
    • FUTURE PERSPECTIVE: THE RISE OF THE ORGANOIDS

CHAPTER 5 STEM CELL APPLICATIONS

  • REGENERATIVE MEDICINE
  • CURRENT APPLICATIONS OF STEM CELL THERAPY
    • CANCER
      • Hematopoiesis (Blood Cell Formation)
    • AMYOTROPHIC LATERAL SCLEROSIS
    • PARKINSON'S DISEASE
    • SPINAL CORD INJURY
    • ALZHEIMER'S DISEASE
    • STROKE
    • HEART DISEASE
      • Doubts Expressed
    • PERIPHERAL ARTERIAL DISEASE
    • TYPE 1 DIABETES
    • ORTHOPEDIC REPAIR
    • LIVER FAILURE
    • GRAFT-VERSUS-HOST DISEASE
    • LUNG DISEASE
    • STATUS OF STEM CELL CLINICAL TRIALS
      • Prochymal-stem Cell Therapy
        • Prochymal-Crohn's Disease and Gastrointestinal Injury from Radiation
      • Mesenchymal Precursor Cell (MPC) Product-Stem Cell Therapy (Orphan Drug)
      • MyoCell-Stem Cell Therapy
      • ixmyelocel-T-Stem Cell Therapy (Fast Track)
      • StemEx (carlecortemcel-L)-Stem Cell Therapy (Orphan Drug) (Fast Track)
      • GSK 2696273-Stem Cell Therapy
      • Adult Autologous Stem Cell Therapy (Renew)-Stem Cell Therapy

CHAPTER 6 STEM CELL PATENTS

  • GENERAL BACKGROUND ON PATENTS
  • STEM CELL PATENTS
    • PATENTABILITY OF STEM CELL LINES
  • INDIVIDUAL COUNTRY POLICIES
    • UNITED STATES
    • CANADA
      • EPC
    • UNITED KINGDOM
    • GERMANY
    • JAPAN
    • CHINA
      • iPS Cells
      • TABLE 2 IPS-RELATED PATENTS (YAMANAKA, 2011)
      • TABLE 3 CLASSIFICATION OF STEM CELL PATENTS

CHAPTER 7 STEM CELL MARKETS

  • MARKETS FOR STEM CELLS
    • MARKET DRIVERS
      • Healthcare
      • TABLE 4 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES
      • Market Restraints
      • Biotechnology
      • Pharmaceutical
  • MARKET OPPORTUNITIES BY THERAPEUTIC CLASS
    • CANCER
      • Other Cancers
    • CARDIOVASCULAR DISEASE
      • Myocardial Infarction
      • TABLE 5 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD
    • CENTRAL NERVOUS SYSTEM DISEASE
      • Spinal Cord Injury (SCI)
      • TABLE 6 STATISTICS FOR SCI IN THE U.S., 2014
      • Neurodegenerative Diseases
      • TABLE 7 NEURODEGENERATIVE DISEASES WORLDWIDE, 2015
    • DIABETES MELLITUS
    • TABLE 8 STATISTICS FOR DIABETES IN THE U.S., 2014
    • TABLE 9 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES, THROUGH 2021 ($ BILLIONS)
    • SKELETAL SYSTEM
  • GLOBAL MARKET ESTIMATES AND FORECASTS
  • TABLE 10 GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
  • REGIONAL AND NATIONAL MARKET ANALYSIS
    • AMERICAS
    • TABLE 11 AMERICAS STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
      • U.S.
      • TABLE 12 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES
      • TABLE 13 U.S. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 14 U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 15 U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Canada
      • TABLE 16 CANADA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 17 CANADA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 18 CANADA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Brazil
      • TABLE 19 BRAZIL STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 20 BRAZIL STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 21 BRAZIL STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Mexico
      • TABLE 22 MEXICO STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 23 MEXICO STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
    • EUROPE
    • TABLE 24 EUROPE STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
      • Market Opportunities by Disease Category
      • TABLE 25 STATISTICS FOR CVD IN EUROPE, 2012
      • TABLE 26 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES)
      • TABLE 27 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013
      • TABLE 28 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2011
      • TABLE 29 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN COUNTRIES, 2013
      • France
      • TABLE 30 FRANCE STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 31 FRANCE STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 32 FRANCE STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Germany
      • TABLE 33 GERMANY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 34 GERMANY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 35 GERMANY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Italy
      • TABLE 36 ITALY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 37 ITALY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 38 ITALY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • Spain
      • TABLE 39 SPAIN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 40 SPAIN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 41 SPAIN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • United Kingdom
      • TABLE 42 U.K. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 43 U.K. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 44 U.K. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
    • ASIA
      • Market Opportunities by Disease Category
      • TABLE 45 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011
      • TABLE 46 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES
      • TABLE 47 ASIA STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
      • Japan
      • TABLE 48 JAPAN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 49 JAPAN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 50 JAPAN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • China
      • TABLE 51 CHINA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 52 CHINA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 53 CHINA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • India
      • TABLE 54 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA
      • TABLE 55 INDIA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 56 INDIA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
      • TABLE 57 INDIA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
    • REST OF WORLD
    • TABLE 58 REST OF WORLD STEM CELL MARKET BY SEGMENT, THROUGH 2021 ($ MILLIONS)

CHAPTER 8 COMPANY PROFILES

  • 3DMATRIX
  • ALDAGEN INC.
  • ANGIOBLAST SYSTEMS
  • ARTERIOCYTE
  • ATHERSYS INC.
  • BEIKE BIOTECHNOLOGY CO. LTD.
  • BIOTIME INC.
  • BRAINSTORM CELL THERAPEUTICS INC.
  • CALADRIUS BIOSCIENCES INC.
  • CAPRICOR INC.
  • CELLERANT THERAPEUTICS INC.
  • CELLERIX SA
  • CELLULAR DYNAMICS INTERNATIONAL
  • CELYAD
  • CLONTECH
  • CYTORI THERAPEUTICS INC.
  • EPISTEM LTD.
  • GAMIDA CELL LTD.
  • GLOBALSTEM
  • HYBRID ORGAN GMBH
  • INTELLICELL BIOSCIENCES INC.
  • INTERNATIONAL STEM CELL CORP.
  • JUVENTAS THERAPEUTICS INC.
  • MESOBLAST LTD.
  • NEURALSTEM
  • NEUROGENERATION
  • OCATA
  • OSIRIS THERAPEUTICS INC.
  • PRIMEGEN BIOTECH LLC
  • RENEURON GROUP
  • RHINOCYTE INC.
  • STEM CELLS INC.
  • STEMCELL TECHNOLOGIES SARL
  • STEM CELL THERAPEUTICS CORP.
  • STEMEDICA CELL TECHNOLOGIES INC.
  • STEMINA BIOMARKER DISCOVERY INC.
  • STEMPEUTICS RESEARCH PVT. LTD.
  • TIGENIX NV
  • U.S. STEM CELL
  • VERASTEM INC.
  • VERICEL
  • VERISTEM TECHNOLOGIES
  • VIACYTE
  • VITRO DIAGNOSTICS INC.
  • WICELL RESEARCH INSTITUTE
  • XPAND BIOTECHNOLOGY BV

CHAPTER 9 GLOSSARY

CHAPTER 10 SIGNIFICANT STEM CELL RESEARCH PATENTS

  • TABLE 59 SIGNIFICANT STEM CELL RESEARCH PATENTS

LIST OF TABLES

  • SUMMARY TABLE GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
  • TABLE 1 COUNTRIES ENGAGED IN THE ISCBI PROGRAM
  • TABLE 2 IPS-RELATED PATENTS (YAMANAKA, 2011)
  • TABLE 3 CLASSIFICATION OF STEM CELL PATENTS
  • TABLE 4 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES
  • TABLE 5 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD
  • TABLE 6 STATISTICS FOR SCI IN THE U.S., 2014
  • TABLE 7 NEURODEGENERATIVE DISEASES WORLDWIDE, 2015
  • TABLE 8 STATISTICS FOR DIABETES IN THE U.S., 2014
  • TABLE 9 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES, THROUGH 2021 ($ BILLIONS)
  • TABLE 10 GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
  • TABLE 11 AMERICAS STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
  • TABLE 12 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES
  • TABLE 13 U.S. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 14 U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 15 U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 16 CANADA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 17 CANADA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 18 CANADA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 19 BRAZIL STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 20 BRAZIL STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 21 BRAZIL STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 22 MEXICO STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 23 MEXICO STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 24 EUROPE STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
  • TABLE 25 STATISTICS FOR CVD IN EUROPE, 2012
  • TABLE 26 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES)
  • TABLE 27 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013
  • TABLE 28 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2011
  • TABLE 29 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN COUNTRIES, 2013
  • TABLE 30 FRANCE STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 31 FRANCE STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 32 FRANCE STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 33 GERMANY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 34 GERMANY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 35 GERMANY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 36 ITALY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 37 ITALY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 38 ITALY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 39 SPAIN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 40 SPAIN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 41 SPAIN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 42 U.K. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 43 U.K. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 44 U.K. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 45 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011
  • TABLE 46 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES
  • TABLE 47 ASIA STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
  • TABLE 48 JAPAN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 49 JAPAN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 50 JAPAN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 51 CHINA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 52 CHINA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 53 CHINA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 54 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA
  • TABLE 55 INDIA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 56 INDIA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 57 INDIA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
  • TABLE 58 REST OF WORLD STEM CELL MARKET BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • TABLE 59 SIGNIFICANT STEM CELL RESEARCH PATENTS

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL STEM CELL MARKET BY REGION, 2014-2021 ($ MILLIONS)
  • FIGURE 1 EARLY DEVELOPMENT OF EMBRYO
Back to Top